Fold (NASDAQ:FLD) executives used the company’s fourth-quarter 2025 earnings call to highlight a year of product expansion ...
A new strain that dominated the early winter was not well matched to the vaccine, leading to an intense early onslaught of flu.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results